CLSA

TriLinc Adds New Asia Investment Partner

Retrieved on: 
Tuesday, October 8, 2019
Banking, Professional services, Finance, Economy, Articles, Corporate social responsibility, Impact investing, Investment, Social finance, CLSA, TriLinc Global, LLC, CLSA Capital Partners, Lending Ark

TriLinc Global, LLC (TriLinc) announced today the approval of CLSA Capital Partners Lending Ark Strategy (Lending Ark) as a new term loan investment partner for business expansion and socioeconomic development in Southeast Asia.

Key Points: 
  • TriLinc Global, LLC (TriLinc) announced today the approval of CLSA Capital Partners Lending Ark Strategy (Lending Ark) as a new term loan investment partner for business expansion and socioeconomic development in Southeast Asia.
  • We are very excited about our partnership with Lending Ark for broadening our existing term loan investment capabilities throughout Asia, commented Gloria Nelund, CEO and founder of TriLinc Global, LLC.
  • TriLinc Global is an impact investing fund sponsor with a mission to link market-rate returns, positive impact, and scalable solutions.
  • TriLinc Global complements its global macroeconomic portfolio organization and management with investment services from experienced investment partners that have established track records in target asset classes and geographies, and access to a high-quality investment pipeline.

Ionis to receive the CLSA's 2019 Pantheon DiNA™ Award for Company of the Year

Retrieved on: 
Wednesday, September 25, 2019
Spinal muscular atrophy, Antisense RNA, Huntington's disease, Ionis Pharmaceuticals, Ionis, CLSA

CARLSBAD, Calif., Sept. 25, 2019 /PRNewswire/ --Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the California Life Sciences Association (CLSA) , the trade association representing California's life sciences sector and its board of directors will honor Ionis with the 2019 Pantheon DiNA Award for Company of the Year.

Key Points: 
  • CARLSBAD, Calif., Sept. 25, 2019 /PRNewswire/ --Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the California Life Sciences Association (CLSA) , the trade association representing California's life sciences sector and its board of directors will honor Ionis with the 2019 Pantheon DiNA Award for Company of the Year.
  • Each award is determined through a rigorous peer-driven process and approved by the CLSA executive committee.
  • "The recipients of the 2019 Pantheon DiNA Awards are some of California's most impactful innovators and entrepreneurs.
  • Ionis is a preeminent example of a company that is making an incredible difference in the lives of patients around the world.

CLSA Names 2019 Pantheon DiNA™ Award Winners, Recognizing Advancements in California Life Sciences

Retrieved on: 
Wednesday, September 25, 2019
Research, Other Health, General Health, Pharmaceutical, Medical devices, Science, Biotechnology, Other Science, Health, Californias, CLSA

California Life Sciences Association (CLSA) , the trade association representing Californias life sciences sector, has announced the 2019 Pantheon DiNA Awards slate of honorees.

Key Points: 
  • California Life Sciences Association (CLSA) , the trade association representing Californias life sciences sector, has announced the 2019 Pantheon DiNA Awards slate of honorees.
  • View the full release here: https://www.businesswire.com/news/home/20190925005277/en/
    Each year the California Life Sciences Association (CLSA) recognizes and honors excellence as it brings together Californias Life Sciences industry for one night at our Annual Pantheon DiNA Awards Ceremony.
  • More about CLSAs Pantheon DiNA Awards:
    Each year the California Life Sciences Association (CLSA) recognizes and honors excellence as it brings together Californias Life Sciences industry for one night at our Annual Pantheon DiNA Awards Ceremony .
  • California Life Sciences Association (CLSA) is the states largest and most influential life sciences advocacy and business leadership organization.

Tourmaline Adds London-Based Managing Director To Meet Increased Demand for Outsourced Trading Services in Europe

Retrieved on: 
Tuesday, September 24, 2019
Economy, Articles, Business, Financial markets, Financial regulation, European Union, Markets in Financial Instruments Directive, Systemic risk, CLSA, Outsourcing

Stamford, CT and London, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Tourmaline Partners, LLC, one of the world's leading outsourced trading solutions firms, today announced the hire of Rowley Aird as Managing Director, Europe.

Key Points: 
  • Stamford, CT and London, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Tourmaline Partners, LLC, one of the world's leading outsourced trading solutions firms, today announced the hire of Rowley Aird as Managing Director, Europe.
  • Since the implementation of MiFID II, Tourmaline has seen a marked increase in demand for its services from funds trading in Europe, especially larger firms looking for supplemental trading, to expand the reach of their trading operations.
  • Over his two-decade career in the financial services industry, Aird has served in a number of key roles, most recently as Head of Trading and Execution Services, Europe at CLSA.
  • Rowley will be instrumental in helping us meet this increased demand while maintaining the high level of service our clients expect.

New Drug Pricing Bill from House Democrat Leadership Threatens to Short-Circuit California Biomedical Innovation

Retrieved on: 
Thursday, September 19, 2019
Biotechnology, Health, Congressional News, Views, Public policy, Government, Healthcare reform, Pharmaceutical, Research, Science, State, Local, Public policy, Californias, California Healthcare Institute, CLSA, The Californias, Spanish Empire

California Life Sciences Association (CLSA), the trade association representing Californias life sciences sector, issued the following statement in response to House Speaker Nancy Pelosis drug pricing proposal unveiled today.

Key Points: 
  • California Life Sciences Association (CLSA), the trade association representing Californias life sciences sector, issued the following statement in response to House Speaker Nancy Pelosis drug pricing proposal unveiled today.
  • This flawed proposal will unnecessarily jeopardize patient care by arbitrarily limiting access to necessary medications, and short-circuit life-saving innovation occurring in Californias world-leading biomedical sector.
  • California Life Sciences Association (CLSA) is the states largest and most influential life sciences advocacy and business leadership organization.
  • CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

California Life Sciences Association (CLSA) Responds to Administration’s Drug Importation Plan

Retrieved on: 
Thursday, August 1, 2019
Medical devices, Congressional News, Views, Public policy, Government, Healthcare reform, Science, Biotechnology, Health, Other Science, White House, Federal Government, State, Local, Public policy, Pharmaceutical, Businesspeople, Donald Trump, Presidency of Donald Trump, United States, Californias, CLSA, California Healthcare Institute

California Life Sciences Association (CLSA), the trade association representing Californias life sciences sector, issued the following statement in response to the Trump Administrations drug importation proposal unveiled today.

Key Points: 
  • California Life Sciences Association (CLSA), the trade association representing Californias life sciences sector, issued the following statement in response to the Trump Administrations drug importation proposal unveiled today.
  • We will also work diligently with our bipartisan California Congressional delegation to educate them on the shortcomings of this plan.
  • California Life Sciences Association (CLSA) is the states largest and most influential life sciences advocacy and business leadership organization.
  • CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

California Life Sciences Association (CLSA) Announces Partnership with Brex to Bring Savings to Members

Retrieved on: 
Friday, June 21, 2019
Banking, Professional services, Pharmaceutical, Medical devices, Science, Biotechnology, Finance, Other Science, Health, Brex, CLSA, Credit card

California Life Sciences Association (CLSA) , the trade association representing Californias life sciences sector, today announced a new life sciences credit card member benefit through its partnership with Brex , the corporate card built for the life sciences that accelerates entrepreneurs and scaling businesses.

Key Points: 
  • California Life Sciences Association (CLSA) , the trade association representing Californias life sciences sector, today announced a new life sciences credit card member benefit through its partnership with Brex , the corporate card built for the life sciences that accelerates entrepreneurs and scaling businesses.
  • View the full release here: https://www.businesswire.com/news/home/20190621005081/en/
    As the latest offering in CLSAs Power Purchasing Program , the new Brex Life Sciences Corporate Card provides exclusive rewards to CLSA members and is specifically tailored for companies in the life sciences sector.
  • CLSA provides the tools and resources necessary to help ensure our states life sciences sector can grow and thrive, said Mike Guerra, President & CEO, California Life Sciences Association (CLSA).
  • California Life Sciences Association (CLSA) is the states largest and most influential life sciences advocacy and business leadership organization.

Brex Launches First Corporate Card For Life Sciences

Retrieved on: 
Tuesday, June 18, 2019
Technology, Online Retail, Internet, Software, Health, Biotechnology, Professional services, Accounting, Banking, Finance, Retail, Research, Science, Brex, CLSA

Brex , the corporate card that accelerates entrepreneurs and scaling businesses, today unveiled a new corporate card specifically tailored for companies in the life sciences industry.

Key Points: 
  • Brex , the corporate card that accelerates entrepreneurs and scaling businesses, today unveiled a new corporate card specifically tailored for companies in the life sciences industry.
  • Unlike any other on the market, the new Brex for Life Sciences corporate card offers instant online underwriting that accounts for both grant and venture funding without requiring personal guarantees from life sciences founders and entrepreneurs.
  • Since its launch, Brex has broadened its offering beyond startups to focus on larger tech companies, ecommerce brands and now life sciences.
  • In connection with its Life Sciences launch, Brex has partnered with the California Life Sciences Association (CLSA) , the trade association representing Californias life sciences sector, to offer the new Brex card with exclusive rewards exclusively to the CLSA membership.

Jefferies Establishes Global Microstrategy Research

Retrieved on: 
Wednesday, May 22, 2019
Professional services, Banking, Consulting, Finance, Investment banks, Information technology, Jefferies Group, Finance, Economy, MicroStrategy, CLSA

Jefferies announced today the appointment of Desh Peramunetilleke as Head of Global Microstrategy Product in Equity Research.

Key Points: 
  • Jefferies announced today the appointment of Desh Peramunetilleke as Head of Global Microstrategy Product in Equity Research.
  • We are very excited to have Desh join Jefferies leading equities platform, commented Peter Forlenza, Jefferies Global Head of Equities.
  • Mr. Peramunetilleke was most recently Head of Microstrategy at CLSA and has over 20 years of equity research experience.
  • Jefferies Group LLC is a wholly-owned subsidiary of Jefferies Financial Group Inc. (NYSE:JEF), a diversified financial services company.

Dan Gilroy Joins New Street Research

Retrieved on: 
Wednesday, May 1, 2019
CLSA, Gilroy

LONDON and NEW YORK, May 1, 2019 /PRNewswire/ -- New Street Research are pleased to announce Dan Gilroy has joined our sales desk in the Americas, servicing the Boston area and other East Coast accounts.

Key Points: 
  • LONDON and NEW YORK, May 1, 2019 /PRNewswire/ -- New Street Research are pleased to announce Dan Gilroy has joined our sales desk in the Americas, servicing the Boston area and other East Coast accounts.
  • Dan was most recently with Stephens Inc., and CLSA, based in Boston.Dan has equity sales experience in both U.S. and international product, and started his career in independent economic and strategy research sales.
  • "We welcome Dan to New Street, and look forward to him building our franchise in Boston and beyond, supporting the recent extension to our TMT research offering.
  • He brings a highly relevant mix of marketing and research experiences to New Street, adding to our existing sales desk in North America,"said Iain Johnston, who founded New Street in London.